Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

This study has been withdrawn prior to enrollment.
(All 29 consented subjects tested negative for the BRCA2 mutation. None started study, so PI decided to close the study.)
Sponsor:
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00386399
First received: October 10, 2006
Last updated: May 12, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)